Trial Profile
Evaluation of the usefullness of perioperative administration of tiotropium and indacaterol in lung cancer patients with COPD.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms PALC
- 28 Jun 2013 New trial record